Related Experiment Video
Updated: Feb 16, 2026

A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice
Published on: October 13, 2018
Irreversible metronidazole encephalopathy in an elderly woman with primary biliary cholangitis
Yuki Onuma1, Masayuki Oki2, Masamichi Komatsu1
1Division of General Internal Medicine Department of Medicine Tokai University Oiso Hospital Isehara Kanagawa Japan.
Abstract:
An 82-year-old woman with primary biliary cholangitis was diagnosed with an irreversible neurological disorder, caused by metronidazole (MNZ)-induced encephalopathy. Although the disorder is a reversible pathological condition, in rare cases, it can cause serious sequelae or could even be fatal. Therefore, medications should be administered carefully, particularly in patients who require long-term administration of large doses or those with liver dysfunction.
Insights
Metronidazole (MNZ) can cause irreversible neurological damage, known as MNZ-induced encephalopathy, even though it is usually reversible. Careful medication use is crucial, especially for patients needing high doses or those with liver issues.
Area of Science:
- Neurology
- Toxicology
- Gastroenterology
Background:
- Primary biliary cholangitis (PBC) is a chronic liver disease.
- Metronidazole (MNZ) is an antibiotic commonly used for various infections.
Observation:
- An 82-year-old woman with PBC developed an irreversible neurological disorder.
- The condition was diagnosed as metronidazole-induced encephalopathy.
Findings:
- Metronidazole-induced encephalopathy, while typically reversible, can lead to severe, permanent neurological deficits in rare instances.
- This case highlights the potential for serious sequelae, including fatality, from MNZ-induced encephalopathy.
Implications:
- Judicious use of metronidazole is essential, particularly in elderly patients or those with compromised liver function.
- Long-term or high-dose metronidazole therapy requires careful monitoring to prevent neurotoxicity.
- This case underscores the importance of considering drug-induced neurological disorders in differential diagnoses, especially in vulnerable patient populations.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Drug Dosing: Geriatric Patients
